跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saphyrefen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saphyrefen
Approved
STANDARD
Saphyrefen
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9cba690e41a19923
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9cba690e41a19923
Drug Approval Philippines Name
Saphyrefen
Product Name
Saphyrefen
Registration Number
DRP-9502
Brand Name
Saphyrefen
Generic Name
Paracetamol + Ibuprofen
Dosage Form
Suspension
Dosage Strength
125 mg/100 mg per 5mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
26 January 2021
Expiry Date
26 January 2026
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9cba690e41a19923
Type
Standard
Back to Philippines FDA Approvals